Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Issue brief | 23 January 2018 142nd WHO EB Agenda item 4.1 - Global snakebite burden TROPICAL & NEGLECTED DISEASES Download May.2018_71st WHO-WHA Global snakebite burden Photograph by Gabriel Martinez Global Snakebite Burden - WHO Executive Board, 142nd Session, January 2018 Provisional agenda item 4.1 (EB142/17)
